## Guidelines For Antibiotic Prophylaxis

Adapted from Bratzler et al.  Am J Health-Syst Pharm. 2013; 70:195-283 

**Wound Class Definitions**
- _Clean:_ An uninfected operative wound in which no inflammation is encountered and the
  	     respiratory, alimentary, genital, or uninfected urinary tracts are not entered.  In addition,
  	     clean wounds are primarily closed and, if necessary, drained with closed drainage.
  	     Operative incisional wounds that follow blunt trauma should be included in this category
  	     if they meet the criteria.

-  _Clean-Contaminated:_ Operative wounds in which the respiratory, alimentary, genital, or
 	      urinary tracts are entered under controlled conditions and without unusual contamination.
 	      Specifically, operations involving the biliary tract, appendix, vagina, and oropharynx are
 	      included in this category, provided no evidence of infection or major break in technique
 	      is encountered.
-  _Clean-Contaminated:_ Operative wounds in which the respiratory, alimentary, genital, or
	      urinary tracts are entered under controlled conditions and without unusual contamination.
	      Specifically, operations involving the biliary tract, appendix, vagina, and oropharynx are
	      included in this category, provided no evidence of infection or major break in technique
	      is encountered.
-  _Contaminated:_ Open, fresh, accidental wounds. In addition, operations with major breaks in
	      sterile technique (e.g., open cardiac massage) or gross spillage from the gastrointestinal 
	      tract and incisions in which acute, non-purulent inflammation is encountered are 
	      included in this category.
-  _Dirty or Infected:_ Includes old traumatic wounds with retained devitalized tissue and those
	      that involve existing clinical infection or perforated viscera.   This definition suggests that 
	      the organisms causing postoperative infection were present in the operative field before 
	      the operation.
	     
**Wound Infection Definitions:**

- _Superficial Incisional SSI:_
	   - Within 30 days of operation involving skin or subcutaneous tissue of incision with either:
          - Purulent drainage
          - Organisms isolated from an aseptically obtained wound culture
          - Or one of the following signs or symptoms:
               - Pain or tenderness
               - Localized swelling
               - Redness or heat
     - And superficial incision is deliberately opened by surgeon
- _Deep Incisional SSI:_
	   - Within 30 days after the operative procedure (or up to 1 year if an implant is in place) involves deep soft tissues of the incision with either:
          - Purulent drainage
          - Spontaneous dehiscence of deep incision opened by surgeon and:
               - Culture positive
               - Temperature >38 °C
               - Localized pain or tenderness
	  - Abscess
- _Organ/Space SSI:_
	   - Any part of the body (excluding skin incision, fascia, or muscle layers) that is opened or manipulated during the operative procedure.
	  - Within 30 days after the operative procedure (or up to 1 year if an implant is in place) involves deep soft tissues of the incision with either:
- Purulent drainage from a drain that is placed through a stab wound into the organ/space
- Organisms isolated from an aseptically obtained culture of fluid or tissue in the organ/space
- Abscess or other evidence of infection involving the organ/space that is found on direct examination, during reoperation, or by histopathologic or radiologic examination.

<style type="text/css">
.tg  {border-collapse:collapse;border-spacing:0;}
.tg td{font-family:Arial, sans-serif;font-size:14px;padding:10px 5px;border-style:solid;border-width:1px;overflow:hidden;word-break:normal;}
.tg th{font-family:Arial, sans-serif;font-size:14px;font-weight:normal;padding:10px 5px;border-style:solid;border-width:1px;overflow:hidden;word-break:normal;}
.tg .tg-yw4l{vertical-align:top}
.tg .tg-jogk{font-style:italic;vertical-align:top}
</style>
<table class="tg">
  <tr>
    <th class="tg-yw4l"><b>Type of Procedure</th></b>
    <th class="tg-yw4l"><b>Recommended Agents</th></b>
    <th class="tg-yw4l"><b>Alternative Agents in Patients with β-Lactam Allergy</th></b>
  </tr>
  <tr>
    <td class="tg-jogk">Cardiac</td>
    <td class="tg-yw4l"></td>
    <td class="tg-yw4l"></td>
  </tr>
  <tr>
    <td class="tg-yw4l">Coronary artery bypass</td>
    <td class="tg-yw4l">Cefazolin, cefuroxime</td>
    <td class="tg-yw4l">Clindamycin, vancomycin </td>
  </tr>
  <tr>
    <td class="tg-yw4l">Cardiac device insertion procedures (e.g., pacemaker implantation) </td>
    <td class="tg-yw4l">Cefazolin, cefuroxime</td>
    <td class="tg-yw4l">Clindamycin, vancomycin</td>
  </tr>
  <tr>
    <td class="tg-yw4l">Ventricular assist devices</td>
    <td class="tg-yw4l">Cefazolin, cefuroxime</td>
    <td class="tg-yw4l">Clindamycin, vancomycin</td>
  </tr>
  <tr>
    <td class="tg-jogk">Thoracic </td>
    <td class="tg-yw4l"></td>
    <td class="tg-yw4l"></td>
  </tr>
  <tr>
    <td class="tg-yw4l">Noncardiac procedures, including lobectomy, pneumonectomy, lung resection, and thoracotomy</td>
    <td class="tg-yw4l">Cefazolin, ampicillin-sulbactam</td>
    <td class="tg-yw4l">Clindamycin, vancomycin</td>
  </tr>
  <tr>
    <td class="tg-yw4l">Video-assisted thoracoscopic surgery</td>
    <td class="tg-yw4l">Cefazolin, ampicillin-sulbactam</td>
    <td class="tg-yw4l">Clindamycin, vancomycin</td>
  </tr>
  <tr>
    <td class="tg-jogk">Gastroduodenale</td>
    <td class="tg-yw4l"></td>
    <td class="tg-yw4l"></td>
  </tr>
  <tr>
    <td class="tg-yw4l">Procedures involving entry into lumen of gastrointestinal tract (bariatric, pancreaticoduodenectomy)</td>
    <td class="tg-yw4l">Cefazolin</td>
    <td class="tg-yw4l">Clindamycin or vancomycin + aminoglycoside or aztreonam or fluoroquinolone</td>
  </tr>
  <tr>
    <td class="tg-yw4l">Procedures without entry into gastrointestinal tract (antireflux, highly selective vagotomy) for high-risk patients</td>
    <td class="tg-yw4l">Cefazolin</td>
    <td class="tg-yw4l">Clindamycin or vancomycin + aminoglycoside or aztreonam or fluoroquinolone</td>
  </tr>
  <tr>
    <td class="tg-jogk">Biliary tract</td>
    <td class="tg-yw4l"></td>
    <td class="tg-yw4l"></td>
  </tr>
  <tr>
    <td class="tg-yw4l">Open procedure</td>
    <td class="tg-yw4l">Cefazolin, cefoxitin, cefotetan, ceftriaxone, ampicillin-sulbactam</td>
    <td class="tg-yw4l">Clindamycin or vancomycin + aminoglycoside or aztreonam or fluoroquinolone, metronidazole + aminoglycoside or fluoroquinolone</td>
  </tr>
  <tr>
    <td class="tg-jogk">Laparoscopic procedure</td>
    <td class="tg-yw4l"></td>
    <td class="tg-yw4l"></td>
  </tr>
  <tr>
    <td class="tg-yw4l">Elective, low-risk</td>
    <td class="tg-yw4l">None</td>
    <td class="tg-yw4l">None</td>
  </tr>
  <tr>
    <td class="tg-yw4l">Elective, high-risk</td>
    <td class="tg-yw4l">Cefazolin, cefoxitin, cefotetan, ceftriaxone, ampicillin-sulbactam</td>
    <td class="tg-yw4l">Clindamycin or vancomycin + aminoglycoside or aztreonamor fluoroquinolone, metronidazole + aminoglycoside or fluoroquinolone</td>
  </tr>
  <tr>
    <td class="tg-yw4l">Appendectomy for uncomplicated appendicitis</td>
    <td class="tg-yw4l">Cefoxitin, cefotetan, cefazolin + metronidazole</td>
    <td class="tg-yw4l">Clindamycin or vancomycin + aminoglycoside or aztreonam or fluoroquinolone, metronidazole + aminoglycoside or fluoroquinolone</td>
  </tr>
  <tr>
    <td class="tg-yw4l">Small intestine</td>
    <td class="tg-yw4l"></td>
    <td class="tg-yw4l"></td>
  </tr>
  <tr>
    <td class="tg-yw4l">Nonobstructed</td>
    <td class="tg-yw4l">Cefazolin</td>
    <td class="tg-yw4l">Clindamycin + aminoglycoside or aztreonam or fluoroquinolone</td>
  </tr>
  <tr>
    <td class="tg-yw4l">Obstructed</td>
    <td class="tg-yw4l">Cefazolin + metronidazole, cefoxitin, cefotetan</td>
    <td class="tg-yw4l">Metronidazole + aminoglycoside or fluoroquinolone</td>
  </tr>
  <tr>
    <td class="tg-yw4l">Hernia repair (hernioplasty and herniorrpaphy)</td>
    <td class="tg-yw4l">Cefazolin</td>
    <td class="tg-yw4l">Clindamycin, vancomycin</td>
  </tr>
</table>
</br>
</br>

<style type="text/css">
.tg  {border-collapse:collapse;border-spacing:0;}
.tg td{font-family:Arial, sans-serif;font-size:14px;padding:10px 5px;border-style:solid;border-width:1px;overflow:hidden;word-break:normal;}
.tg th{font-family:Arial, sans-serif;font-size:14px;font-weight:normal;padding:10px 5px;border-style:solid;border-width:1px;overflow:hidden;word-break:normal;}
.tg .tg-e3zv{font-weight:bold}
.tg .tg-jogk{font-style:italic;vertical-align:top}
.tg .tg-yw4l{vertical-align:top}
</style>
<table class="tg">
  <tr>
    <th class="tg-e3zv">Type of Procedure</th>
    <th class="tg-e3zv">Recommended Agents</th>
    <th class="tg-e3zv">Alternative Agents in Patients with β-Lactam Allergy</th>
  </tr>
  <tr>
    <td class="tg-031e">Colorectal</td>
    <td class="tg-031e">Cefazolin + metronidazole, cefoxitin, cefotetan, ampicillin-sulbactam, ceftriaxone + metronidazole, ertapenem</td>
    <td class="tg-031e"></td>
  </tr>
  <tr>
    <td class="tg-jogk">Head and Neck</td>
    <td class="tg-yw4l"></td>
    <td class="tg-yw4l"></td>
  </tr>
  <tr>
    <td class="tg-yw4l">Clean</td>
    <td class="tg-yw4l">None</td>
    <td class="tg-yw4l">None</td>
  </tr>
  <tr>
    <td class="tg-yw4l">Clean with placement of prosthesis (excludes tympanostomy tubes)</td>
    <td class="tg-yw4l">Cefazolin, cefuroxime</td>
    <td class="tg-yw4l">Clindamycin</td>
  </tr>
  <tr>
    <td class="tg-yw4l">Clean-contaminated cancer surgery</td>
    <td class="tg-yw4l">Cefazolin + metronidazole, cefuroxime + metronidazole, ampicillin-sulbactam</td>
    <td class="tg-yw4l">Clindamycin</td>
  </tr>
  <tr>
    <td class="tg-yw4l">Other clean-contaminated procedures with the exception of tonsillectomy and functional endoscopic sinus procedures</td>
    <td class="tg-yw4l">Cefazolin + metronidazole, cefuroxime + metronidazole, ampicillin-sulbactam</td>
    <td class="tg-yw4l">Clindamycin</td>
  </tr>
  <tr>
    <td class="tg-jogk">Neurosurgery</td>
    <td class="tg-yw4l"></td>
    <td class="tg-yw4l"></td>
  </tr>
  <tr>
    <td class="tg-yw4l">Elective craniotomy and cerebrospinal fluid-shunting procedures</td>
    <td class="tg-yw4l">Cefazolin</td>
    <td class="tg-yw4l">Clindamycin, vancomycin</td>
  </tr>
  <tr>
    <td class="tg-yw4l">Implantation of intrathecal pumps</td>
    <td class="tg-yw4l">Cefazolin</td>
    <td class="tg-yw4l">Clindamycin, vancomycin</td>
  </tr>
  <tr>
    <td class="tg-yw4l">Cesarean delivery</td>
    <td class="tg-yw4l">Cefazolin</td>
    <td class="tg-yw4l">Clindamycin + aminoglycoside</td>
  </tr>
  <tr>
    <td class="tg-yw4l">Hysterectomy (vaginal or abdominal) </td>
    <td class="tg-yw4l">Cefazolin, cefotetan, cefoxitin, ampicillin-sulbactam</td>
    <td class="tg-yw4l">Clindamycin or vancomycin + aminoglycoside or azetreonam or fluoroquinolone<br>Metronidazole + aminoglycoside or fluoroquinolone</td>
  </tr>
  <tr>
    <td class="tg-yw4l">Ophthnalmic</td>
    <td class="tg-yw4l">Topical neomycin-polymxin B-gramicidin or fourth generation topical fluoroquinolones (gatifloxacin or moxifloxacin) given as 1 drop every 5-15 min for 5 doses. <br>Addition of cefazolin 100mg by subconjunctival injection or intracameral cefazolin 1-2.5 mg or cefuroxime 1 mg at the end of the procedure is optional </td>
    <td class="tg-yw4l">None</td>
  </tr>
  <tr>
    <td class="tg-jogk">Orthopedic</td>
    <td class="tg-yw4l"></td>
    <td class="tg-yw4l"></td>
  </tr>
  <tr>
    <td class="tg-yw4l">Clean operations involving hand, knee, or foot and not involving implantation of foreign materials</td>
    <td class="tg-yw4l">None</td>
    <td class="tg-yw4l">None</td>
  </tr>
  <tr>
    <td class="tg-yw4l">Spinal procedures with and without instrumentation</td>
    <td class="tg-yw4l">Cefazolin</td>
    <td class="tg-yw4l">Clindamycin, vancomycin</td>
  </tr>
  <tr>
    <td class="tg-yw4l">Hip fracture repair</td>
    <td class="tg-yw4l">Cefazolin</td>
    <td class="tg-yw4l">Clindamycin, vancomycin</td>
  </tr>
</table>

</br>
</br>
<style type="text/css">
.tg  {border-collapse:collapse;border-spacing:0;}
.tg td{font-family:Arial, sans-serif;font-size:14px;padding:10px 5px;border-style:solid;border-width:1px;overflow:hidden;word-break:normal;}
.tg th{font-family:Arial, sans-serif;font-size:14px;font-weight:normal;padding:10px 5px;border-style:solid;border-width:1px;overflow:hidden;word-break:normal;}
.tg .tg-e3zv{font-weight:bold}
.tg .tg-yw4l{vertical-align:top}
.tg .tg-jogk{font-style:italic;vertical-align:top}
</style>
<table class="tg">
  <tr>
    <th class="tg-e3zv">Type of Procedure</th>
    <th class="tg-e3zv">Recommended Agents</th>
    <th class="tg-e3zv">Alternative Agents in Patients with β-Lactam Allergy</th>
  </tr>
  <tr>
    <td class="tg-031e">Implantation of internal fixation devices (e.g., nails, screws, plates, wires)</td>
    <td class="tg-031e">Cefazolin</td>
    <td class="tg-031e">Clindamycin, vancomycin</td>
  </tr>
  <tr>
    <td class="tg-yw4l">Total joint replacement</td>
    <td class="tg-yw4l">Cefazolin</td>
    <td class="tg-yw4l">Clindamycin, vancomycin</td>
  </tr>
  <tr>
    <td class="tg-jogk">Urologic</td>
    <td class="tg-yw4l"></td>
    <td class="tg-yw4l"></td>
  </tr>
  <tr>
    <td class="tg-yw4l">Lower tract instrumentation with risk factors for infection (includes transrectal prostate biopsy)</td>
    <td class="tg-yw4l">Fluoroquinolone, trimethoprim-sulfamethoxazole, cefazolin</td>
    <td class="tg-yw4l">Aminoglycoside with or without clindamycin</td>
  </tr>
  <tr>
    <td class="tg-yw4l">Clean without entry into urinary tract</td>
    <td class="tg-yw4l">Cefazolin (the addition of a single dose of an aminoglycoside may be recommended for placement of prosthetic material [e.g., penile prosthesis])</td>
    <td class="tg-yw4l">Clindamycin, vancomycin</td>
  </tr>
  <tr>
    <td class="tg-yw4l">Involving implanted prosthesis</td>
    <td class="tg-yw4l">Cefazolin ± aminoglycoside, cefazolin ± aztreonam, ampicillin-sulbactam</td>
    <td class="tg-yw4l">Clindamycin ± aminoglycoside or aztreonam, vancomycin ± aminoglycoside or aztreonam</td>
  </tr>
  <tr>
    <td class="tg-yw4l">Clean with entry into urinary tract</td>
    <td class="tg-yw4l">Cefazolin (the addition of a single dose of an aminoglycoside may be recommended for placement of prosthetic material [e.g., penile prosthesis])</td>
    <td class="tg-yw4l">Fluoroquinolone, aminoglycoside with or without clindamycin</td>
  </tr>
  <tr>
    <td class="tg-yw4l">Clean-contaminated </td>
    <td class="tg-yw4l">Cefazolin + metronidazole, cefoxitin</td>
    <td class="tg-yw4l">Fluoroquinolone, aminoglycoside + metrinodazole, or clindamycin</td>
  </tr>
  <tr>
    <td class="tg-yw4l">Vascular</td>
    <td class="tg-yw4l">Cefazolin</td>
    <td class="tg-yw4l">Clindamycin, vancomycin</td>
  </tr>
  <tr>
    <td class="tg-jogk">Heart, lung, heart-lung transplantation</td>
    <td class="tg-yw4l"></td>
    <td class="tg-yw4l"></td>
  </tr>
  <tr>
    <td class="tg-yw4l">Heart transplantation</td>
    <td class="tg-yw4l">Cefazolin</td>
    <td class="tg-yw4l">Clindamycin, vancomycin</td>
  </tr>
  <tr>
    <td class="tg-yw4l">Lung and heart-lung transplantation</td>
    <td class="tg-yw4l">Cefazolin</td>
    <td class="tg-yw4l">Clindamycin, vancomycin</td>
  </tr>
  <tr>
    <td class="tg-yw4l">Liver transplantation</td>
    <td class="tg-yw4l">Piperacilin-tazobactam, cefotaxime + ampicillin</td>
    <td class="tg-yw4l">Clindamycin or vancomycin + aminoglycoside or aztreonam or fluoroquinolone</td>
  </tr>
  <tr>
    <td class="tg-yw4l">Pancreas and pancreas-kidney transplantation</td>
    <td class="tg-yw4l">Cefazolin, fluconazole (for patients at high risk of fungal infection [e.g., those with enteric drainage of the pancrease])</td>
    <td class="tg-yw4l">Clindamycin or vancomycin + aminoglycoside or aztreonam or fluoroquinolone</td>
  </tr>
</table>